IE37961L - 6-(ó-amidino-and imidoylaminoalkenylamino) penicillanic¹acids - Google Patents

6-(ó-amidino-and imidoylaminoalkenylamino) penicillanic¹acids

Info

Publication number
IE37961L
IE37961L IE731303A IE130373A IE37961L IE 37961 L IE37961 L IE 37961L IE 731303 A IE731303 A IE 731303A IE 130373 A IE130373 A IE 130373A IE 37961 L IE37961 L IE 37961L
Authority
IE
Ireland
Prior art keywords
hydrochloride
alkylene
prepared
acid
penicillins
Prior art date
Application number
IE731303A
Other versions
IE37961B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE37961L publication Critical patent/IE37961L/en
Publication of IE37961B1 publication Critical patent/IE37961B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1418656 Penicillins PFIZER Inc 27 Dec 1972 [2 Aug 1972] 59711/72 Heading C2C Novel penicillins having the Formula (I) or (II) and salts thereof, wherein Ar is phenyl, 4- hydroxyphenyl or 2- or 3-thienyl; A is 1,4- phenylene, C 1 -C 3 alkylene or C 2 -C 3 alkylidene; R 1 and R 2 are each hydrogen, C 1 -C 3 alkyl; naphthyl, thienyl, pyrryl, pyridyl, furyl, phenyl, benzyl, or substituted phenyl or benzyl wherein the substituent is Cl, Br, F, CH 3 , CH 3 O, CF 3 , 3,4-dichloro or 3,5-dichloro; or R 1 and R 2 together are C 2 -C 6 alkylene; and R 2 and R 3 together can be C 2 -C 4 alkylene, and R 2 and R 4 together can be C 3 -C 5 alkylene; are prepared by reacting an appropriate α-amino arylacetamido-penicillin or a salt thereof with a compound of formula wherein R is X is OH or Cl, and R 1 , R 2 , R 3 and R 4 are as defined above, in the presence of a condensing agent or acid binding agent respectively. The penicillins (I) and (II) have antibiotic activity, and may be made up into antibacterially active pharmaceutical compositions with conventional pharmaceutical diluents or carriers. The following starting materials and intermediates are also prepared: 3-amidinopropionic acid hydrochloride is produced by reacting methanol, methyl-3-cyanopropionate and HCl to give methyl #-carbomethoxypropionamidate hydrochloride which is treated with ammonia to give #-carbomethoxypropionamidine hydrochloride, the latter then being hydrolysed with 12N hydrochloric acid. By analogous procedure, many other compounds of formula where R 1 , R 2 , R 3 and A are as defined above, are prepared. N,N<SP>1</SP> - Diethylamidinoacetic acid hydrochloride is prepared via N-ethyl-carboethoxyacetamide, methyl N - ethyl - carboethoxyacetamide and N,N<SP>1</SP> - diethyl - carboethoxyacetamidine hydrochloride. Other analogues wherein R 1 , R 2 , R 3 and A are as before are similarly produced. Other compounds produced are 3-(2-imidazolinyl)propionic acid hydrochloride, 3-amidinopropionyl chloride hydrochloride, ethyl isobutyrimidate hydrochloride, isobutyrimidoylaminoacetic acid hydrochloride and the corresponding free base; N - (N<SP>1</SP> - methylacetimidoyl)aminoacetic hydrochloride, 2 - (N - n - propyl - N - carboxymethyl)amino - 1 - aza - cyclohept - 2 - ene hydrochloride, N - carboxymethylimidazoline hydrochloride, N - carbobenzyloxymethyl - imidazoline; formimidoylaminoacetyl chloride hydrochloride; and benzimidoylaminoacetyl chloride hydrochloride. [GB1418656A]
IE1303/73A 1972-08-02 1973-07-31 6-(alpha-(amidino-and imidoylaminoalkanoylamino)penicillanic acids IE37961B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27706472A 1972-08-02 1972-08-02

Publications (2)

Publication Number Publication Date
IE37961L true IE37961L (en) 1974-02-02
IE37961B1 IE37961B1 (en) 1977-11-23

Family

ID=23059254

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1303/73A IE37961B1 (en) 1972-08-02 1973-07-31 6-(alpha-(amidino-and imidoylaminoalkanoylamino)penicillanic acids

Country Status (30)

Country Link
JP (1) JPS5318039B2 (en)
AR (1) AR206879A1 (en)
AT (1) AT327382B (en)
AU (1) AU472676B2 (en)
BE (1) BE803094A (en)
BG (1) BG25798A3 (en)
CA (1) CA1015355A (en)
CH (1) CH574447A5 (en)
CS (1) CS168459B2 (en)
DD (1) DD106849A5 (en)
DE (1) DE2338389A1 (en)
DK (1) DK137047B (en)
EG (1) EG10896A (en)
ES (1) ES417461A1 (en)
FI (1) FI56840C (en)
FR (1) FR2194415B1 (en)
GB (1) GB1418656A (en)
HU (1) HU167653B (en)
IE (1) IE37961B1 (en)
IL (1) IL42820A (en)
LU (1) LU68143A1 (en)
NL (1) NL7310696A (en)
NO (1) NO144831C (en)
PH (1) PH12770A (en)
PL (1) PL96500B1 (en)
RO (2) RO68719A2 (en)
SE (1) SE415977B (en)
SU (2) SU576944A3 (en)
YU (1) YU36966B (en)
ZA (1) ZA735236B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024130A (en) * 1975-03-31 1977-05-17 Pfizer Inc. Process for the manufacture of alkali metal salts of 6-[2-phenyl-2-(imidoylaminoalkanoylamino)acetamido]penicillanic acids
US4073780A (en) * 1976-06-03 1978-02-14 Pfizer Inc. 4-Pyridylformimidoylglycyl-D-phenylglycine

Also Published As

Publication number Publication date
GB1418656A (en) 1975-12-24
NL7310696A (en) 1974-02-05
AT327382B (en) 1976-01-26
HU167653B (en) 1975-11-28
FI56840C (en) 1980-04-10
RO63748A (en) 1979-01-15
FI56840B (en) 1979-12-31
SU576944A3 (en) 1977-10-15
EG10896A (en) 1976-07-31
JPS5318039B2 (en) 1978-06-13
RO68719A2 (en) 1980-08-15
AU472676B2 (en) 1976-06-03
DK137047C (en) 1978-08-07
IL42820A0 (en) 1973-10-25
FR2194415A1 (en) 1974-03-01
SE415977B (en) 1980-11-17
IL42820A (en) 1977-06-30
BE803094A (en) 1974-02-01
ZA735236B (en) 1974-07-31
LU68143A1 (en) 1974-02-11
CH574447A5 (en) 1976-04-15
PH12770A (en) 1979-08-17
DE2338389A1 (en) 1974-02-28
NO144831C (en) 1981-11-18
AR206879A1 (en) 1976-08-31
AU5843373A (en) 1975-01-30
FR2194415B1 (en) 1976-12-31
ATA680773A (en) 1975-04-15
IE37961B1 (en) 1977-11-23
JPS4945089A (en) 1974-04-27
YU208673A (en) 1982-02-25
SU576945A3 (en) 1977-10-15
DD106849A5 (en) 1974-07-05
NO144831B (en) 1981-08-10
CA1015355A (en) 1977-08-09
CS168459B2 (en) 1976-06-29
DK137047B (en) 1978-01-09
PL96500B1 (en) 1977-12-31
YU36966B (en) 1984-08-31
BG25798A3 (en) 1978-12-12
ES417461A1 (en) 1976-03-01

Similar Documents

Publication Publication Date Title
GB1432576A (en) Substituted phenylacetic acids
IE41474L (en) Thiomethylergolines
IE43272L (en) 1-aryl-2-(1-imidazolyl) alkyl ethers
GB1468012A (en) 2-amino-3-carboxy-thiophene derivatives
GB1456221A (en) 3-hydroxy cephalosporins their ether derivatives and methods for their preparation
GB1505885A (en) Substituted cephalosporins
GB1244975A (en) Benzodioxane derivatives
IE37961L (en) 6-(ó-amidino-and imidoylaminoalkenylamino) penicillanic¹acids
ES457993A1 (en) Isothiazolo-pyridines
IE36247L (en) Hydroxy-cinnamic acid derivatives
GB1526793A (en) 7alpha-methoxycephalosporins
GB1336318A (en) Derivatives of 7-aminocephalosporanic acid
US4130653A (en) Method of treating hypertension
GB1432816A (en) Pharmaceutical antimycotic compositions medicaments and method
GB1515060A (en) 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters
GB1426869A (en) Penicillins
ES478643A1 (en) Therapeutically useful N-phenylaniline derivatives
GB1497729A (en) Benzenesulphonyl ureas and process for their manufacture
US4169149A (en) Use of α-mercapto-β-arylacrylic acid derivatives in heavy metal poisoning
US3951952A (en) Broad spectrum antibiotics
IE781467L (en) 4&#34;-ureido-oleandomycin derivatives
GB1388400A (en) Derivatives of alpha-aminocephalosporins
KR910011815A (en) Thiazolyl-5-carbonamide derivatives and preparation method thereof
GB1436480A (en) Spiro-compounds and thir preparation
US4226882A (en) Use of α,α&#39;-dithiobis-(β-arylacrylic acid) derivatives in the treatment of hypertension